Dechra Pharmaceuticals PLC
23 October 2003
Issued by Citigate Dewe Rogerson, Birmingham
Date: Thursday 23 October 2003 Immediate Release
Dechra Pharmaceuticals PLC
Annual General Meeting
At today's (23 October 2003) Annual General Meeting, Michael Redmond, Chairman,
told shareholders:
'As I indicated in my statement in the 2003 Annual Report, we are already
benefiting from a number of initiatives introduced across our businesses which
have assisted in improving group operating margin.
'I am pleased to report that the improved group performance witnessed in the
second half in comparison to the first half of the financial year ended 30 June
2003 has continued. As a result pre tax profit in the first quarter has shown
an improvement over the same period last year.
'Your Board remains confident the group will continue to make progress.'
All resolutions were duly passed.
Enquiries:
Michael Redmond, Non-Executive Chairman Fiona Tooley (mobile: 07785 703523)
Ian Page, Chief Executive or Katie Dale
mobile: 07775 642222) Citigate Dewe Rogerson
Dechra(R) Pharmaceuticals PLC Tel: 0121 455 8370
Tel: 01782 771100
www.dechra.com
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.